MSKCC Clinical Research Methodology Curriculum
MSKCC 临床研究方法学课程
基本信息
- 批准号:6846436
- 负责人:
- 金额:$ 27.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-06-01 至 2010-05-31
- 项目状态:已结题
- 来源:
- 关键词:biomarkerbiomedical equipment developmentclinical researchcurriculumdata collection methodology /evaluationdata managementdrug design /synthesis /productioneducation evaluation /planningepidemiologyethicsexperimental designshealth science research potentialinterdisciplinary collaborationoutcomes researchpsychometricsstatistics /biometrytechnical writingtrainingworkshop
项目摘要
DESCRIPTION (provided by applicant):
This competing application seeks to renew the didactic Clinical Research Methodology Curriculum (CRMC) at Memorial Sloan-Kettering Cancer Center (MSKCC). Faculty from the Departments of Anesthesiology and Critical Care, Epidemiology and Biostatistics, Medicine, Surgery, Radiation Oncology, Pediatrics, Neurology, Urology, Psychiatry and Behavioral Sciences will participate in a two-year, multidisciplinary program that provides the didactic course work and fundamental skills required for a successful career as an independent clinical researcher. The proposed curriculum represents a substantial enhancement and programmatic evolution from the initial application. Four didactic research methodology modules provide comprehensive and in-depth instruction in the methodology and theory fundamental to sound clinical research. They include: 1) Investigational drug and medical device development from pre-clinical testing to FDA approval; 2) Clinical research in outcomes analysis, psychometric measurements, biological markers, and epidemiology; 3) Ethical conduct, regulations involving human subject research, data management, reporting responsibilities, institutional oversight, and conflict of interest in clinical investigations; 4) Clinical trial designs, integration of correlative sciences, ethical considerations, and regulatory oversight. The curriculum also includes a course in biostatistics and highly interactive workshops in both grant writing and clinical protocol development that provide additional training in hypothesis testing and clinical trial methodology. Since its inception, the program has been successful in achieving its goal of training independent clinical researchers in diverse disciplines including Obstetrics and Gynecology, Orthopedic Surgery, Otolaryngology, General Surgery, Urology, Oncology, Pediatric Oncology, Neurology, Psychiatry and Behavioral Sciences, and Radiation Oncology. These investigators have outstanding records of academic matriculation and extramural funding for their clinical research and have published over 300 manuscripts. The independent clinical investigators trained by this curriculum are already emerging leaders in biomedical research, providing intellectual leadership as Principal or Co-Principal Investigators for 75 IRB-approved research protocols nationwide. This competitive renewal demonstrates our substantial commitment to the training of clinical investigators and the success of the CRMC in achieving that goal.
描述(由申请人提供):
这一竞争性申请旨在更新纪念斯隆-凯特琳癌症中心(MSKCC)的教学临床研究方法课程(CRMC)。 来自麻醉学和重症监护,流行病学和生物统计学,医学,外科,放射肿瘤学,儿科,神经病学,泌尿学,精神病学和行为科学部门的教师将参加为期两年的多学科课程,该课程提供教学课程工作和作为独立临床研究人员成功职业所需的基本技能。 拟议的课程是从最初的应用程序的大幅增强和方案演变。 四个教学研究方法模块提供了全面和深入的指导方法和理论基础健全的临床研究。 它们包括:1)从临床前测试到FDA批准的研究药物和医疗器械开发; 2)结局分析、心理测量、生物标志物和流行病学的临床研究; 3)涉及人类受试者研究的道德行为、法规、数据管理、报告责任、机构监督和临床研究中的利益冲突; 4)临床试验设计,相关科学的整合,伦理考虑和监管监督。 该课程还包括生物统计学课程和高度互动的研讨会,包括赠款写作和临床方案制定,提供假设检验和临床试验方法的额外培训。 自成立以来,该计划已成功地实现了培训独立的临床研究人员在不同学科的目标,包括妇产科,骨科手术,耳鼻喉科,普通外科,泌尿外科,肿瘤学,儿科肿瘤学,神经病学,精神病学和行为科学,放射肿瘤学。 这些研究人员有学术预科和校外资助他们的临床研究的杰出记录,并发表了300多篇手稿。 通过本课程培训的独立临床研究者已经是生物医学研究的新兴领导者,为全国75个IRB批准的研究方案提供了主要或共同主要研究者的知识领导。 这一竞争性更新表明了我们对临床研究者培训的实质性承诺以及CRMC在实现这一目标方面的成功。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dean F. Bajorin其他文献
428: Clinical Outcome of Intermediate- and Poor-Risk Patients with Non-Seminomatous Germ Cell Testicular Cancer (NSGCT) Following Post-Chemotherapy Retroperitoneal Lymph Node Dissection (PC-RPLND)
- DOI:
10.1016/s0022-5347(18)34681-0 - 发表时间:
2005-04-01 - 期刊:
- 影响因子:
- 作者:
Bobby Shayegan;Brett S. Carver;Andrew J. Stephenson;Dean F. Bajorin;Robert J. Motzer;George J. Basl;Joel Sheinfeld - 通讯作者:
Joel Sheinfeld
930: Clinical Outcome and Postoperative Chemotherapy Requirement in Patients with Clinical Stage IIA and IIB Non-Seminomatous Germ Cell Tumor (NSGCT) Following Primary Retroperitoneal Lymph Node Dissection: Impact of Preoperative Serum Tumor Markers (STM)
- DOI:
10.1016/s0022-5347(18)38179-5 - 发表时间:
2004-04-01 - 期刊:
- 影响因子:
- 作者:
Joel Sheinfeld;Andrew J. Stephenson;Robert J. Motzer;Dean F. Bajorin;George J. Bosl - 通讯作者:
George J. Bosl
429: Postchemotherapy Retroperitoneal Lymph Node Dissection for Patients with Elevated Tumor Serum Markers
- DOI:
10.1016/s0022-5347(18)34682-2 - 发表时间:
2005-04-01 - 期刊:
- 影响因子:
- 作者:
Zohar A. Dotan;Fernando J. Bianco;Jason P. Stasi;Robert J. Motzer;Dean F. Bajorin;George J. Bosl;Joel Sheinfeld - 通讯作者:
Joel Sheinfeld
MP77-20 FGFR3 MUTATION ASSOCIATES WITH IMPROVED CANCER SPECIFIC OUTCOME IN UPPER TRACT UROTHELIAL CARCINOMA
- DOI:
10.1016/j.juro.2014.02.2483 - 发表时间:
2014-04-01 - 期刊:
- 影响因子:
- 作者:
John P. Sfakianos;Eugene K. cha;Philip H. kim;Gopa Iyer;A.A. Hakimi;Sasinya N. Scott;Ricardo Ramirez;Aphrothiti J. Hanrahan;Jonathan E. Rosenberg;Qinghu Ren;Hikmat Al-Ahmadie;Guido Dalbagni;Dean F. Bajorin;Michael F. Berger;Bernard H. Bochner;David B. Solit;Jonathan A. Coleman - 通讯作者:
Jonathan A. Coleman
Molecular, immunohistochemical and morphologic analysis of urothelial carcinoma with ERBB2/ERBB3 mutations
- DOI:
10.1097/01.pat.0000454567.82822.1a - 发表时间:
2014-01-01 - 期刊:
- 影响因子:
- 作者:
Qinghu Ren;Philip H. Kim;John P. Sfakianos;Eugene K. Cha;Sasinya Scott;Gopakumar Iyer;Anupama Gandhi;Aphrothiti J. Hanrahan;Satish K. Tickoo;Samson W. Fine;Anuradha Gopalan;Ying-Bei Chen;Jonathan E. Rosenberg;Dean F. Bajorin;Bernard H. Bochner;Victor E. Reuter;Michael F. Berger;David B. Solit;Hikmat A. Al-Ahmadie - 通讯作者:
Hikmat A. Al-Ahmadie
Dean F. Bajorin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dean F. Bajorin', 18)}}的其他基金
RP-2: Discovery and Characterization of Novel Genes and DNA Repair Pathways Predisposing to Urothelial Cancer
RP-2:易患尿路上皮癌的新基因和 DNA 修复途径的发现和表征
- 批准号:
9979819 - 财政年份:2018
- 资助金额:
$ 27.64万 - 项目类别:
RP-2: Discovery and Characterization of Novel Genes and DNA Repair Pathways Predisposing to Urothelial Cancer
RP-2:易患尿路上皮癌的新基因和 DNA 修复途径的发现和表征
- 批准号:
10453634 - 财政年份:2018
- 资助金额:
$ 27.64万 - 项目类别: